Clinical Trials · NCT05443568
A Research Study Looking at How Oral Semaglutide Works in People With Type 2 Diabetes in Israel, as Part of Local Clinical Practice
- Phase
- N/A
- Recruitment status
- Completed
- Sponsor
- Novo Nordisk A/S
- Enrollment
- 155
- Start date
- Mar 2023
- Locations
- 1 site, Israel
- Primary endpoint
- Change in HbA1c (Glycated haemoglobin)